$2.84
-0.07-2.41%
Last update: Nov 2, 9:28 AM
bioAffinity Technologies Inc
BIAFNASDAQ
bioAffinity Technologies (BIAF) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
bioAffinity Technologies (BIAF) last issued guidance on March 31, 2025 for fiscal year 2025. The company guided revenue in the range of $6M - $8M for the period.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | — | $-36.00 | $-40.50 | $-40.50 |
| Actual | $-9.60 | $-12.15 | $-16.65 | $-71.10 |
| Surprise | — | +66.3% | +58.9% | -75.6% |
| Revenue | ||||
| Estimate | — | $1.5M | $1.4M | $1.4M |
| Actual | $1.5M | $1.4M | $1.6M | $1.4M |
| Surprise | — | -8.83% | +12.9% | +2.48% |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | May 8, 2026 | $-12.15 | $-36.00 | 66.3 % |
| Q4 | Mar 13, 2026 | $-16.65 | $-40.50 | 58.9 % |
| Q3 | Nov 14, 2025 | $-71.10 | $-40.50 | -75.6 % |
| Q2 | Aug 14, 2025 | $-76.50 | $-45.00 | -70.0 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | May 8, 2026 | $1.35M | $1.48M | -8.83 % |
| Q4 | Mar 13, 2026 | $1.59M | $1.41M | 12.9 % |
| Q3 | Nov 14, 2025 | $1.45M | $1.41M | 2.48 % |
| Q2 | Aug 14, 2025 | $1.27M | $1.51M | -15.7 % |
